BRCA1 and ductal breast carcinoma in situ: The major aim of this study was to establish whether or not BRCA1/2 mutations confer an increased risk of DCIS in the Polish population, and if DCIS may be a part of hereditary breast and/or ovarian cancer syndrome caused by mutations of BRCA1/2.